(Q37138673)

18 August 2017

1 reference

title

Homocysteine, B-vitamins and CVD. (English)

1 reference

18 August 2017

0 references

0 references

2

Kristina Pentieva

1 reference

18 August 2017

Helene McNulty

1

1 reference

18 August 2017

Leane Hoey

series ordinal

3

1 reference

18 August 2017

Mary Ward

series ordinal

4

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Proceedings of the Nutrition Society

18 August 2017

published in

1 reference

18 August 2017

volume

67

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

232-237

1 reference

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Improvement in stroke mortality in Canada and the United States, 1990 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Efficacy of folic acid supplementation in stroke prevention: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Inflammation, homocysteine, and vitamin B6 status after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Low Vitamin B6 but Not Homocyst(e)ine Is Associated With Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain Fortification

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Cobalamin: a critical vitamin in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Vitamin Intervention For Stroke Prevention trial: an efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Folic Acid for the Prevention of Colorectal Adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Randomized trial of folic acid supplementation and serum homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Effects of vitamin B-6 on (n-3) polyunsaturated fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Occupancy of glycoprotein IIb/IIIa by B-6 vitamers inhibits human platelet aggregation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108007076

7 January 2021

10.1017/S0029665108007076

Identifiers

DOI

1 reference

18 August 2017

1 reference